Matches in SemOpenAlex for { <https://semopenalex.org/work/W2953623861> ?p ?o ?g. }
- W2953623861 endingPage "508" @default.
- W2953623861 startingPage "495" @default.
- W2953623861 abstract "Background: Trial evidence supports statin use after ischemic stroke and recent American, European and British guidelines recommend high-intensity statins for this indication. Limited data are available describing current statin use among these patients in unselected settings. We conducted a cohort study to examine secular trends and factors associated with statin use and dose following ischemic stroke. Methods: A retrospective cohort study of patients with first ischemic stroke between 2000 and 2014 was conducted using the Clinical Practice Research Datalink (CPRD). Proportions of statin users and high-intensity statin users within 2 years after stroke were estimated for each calendar year. We used Cox regression models to explore potential factors associated with statin use and Poisson regression models to calculate risk ratios for the use of a high-intensity statin. Results: A total of 80,442 patients with first stroke were analyzed. The proportion using statins within 2 years after stroke increased from 25% in 2000 to 70% in 2006 and remained at about 75% through 2014. Among post-stroke statin users, high-intensity use accounted for approximately 15% between 2004 and 2011 and then increased to almost 35% in 2014. Older patients (aged ≥75 years), younger patients (<45 years), patients with no prior statin treatment, dementia, underweight, or absence of cardiovascular factors (coronary heart disease, smoking, obesity, diabetes, hypertension, or transient ischemic attack) were less likely to use statins and less likely to receive a high-intensity statin. Conclusion: There has been an increase over time in both statin use and dose, but many patients with ischemic stroke continue to be under-treated. Clinical trials and policy interventions to improve appropriate post-stroke statin use should focus on younger and older patients, patients with no pre-stroke statin treatment, and patients without additional cardiovascular risk factors." @default.
- W2953623861 created "2019-07-12" @default.
- W2953623861 creator A5018869790 @default.
- W2953623861 creator A5034203110 @default.
- W2953623861 creator A5040245841 @default.
- W2953623861 creator A5048126509 @default.
- W2953623861 creator A5062493290 @default.
- W2953623861 creator A5085651175 @default.
- W2953623861 date "2019-06-01" @default.
- W2953623861 modified "2023-10-09" @default.
- W2953623861 title "<p>Statin use and high-dose statin use after ischemic stroke in the UK: a retrospective cohort study</p>" @default.
- W2953623861 cites W1546258268 @default.
- W2953623861 cites W1922625321 @default.
- W2953623861 cites W1972661406 @default.
- W2953623861 cites W1978449788 @default.
- W2953623861 cites W2003951897 @default.
- W2953623861 cites W2013818621 @default.
- W2953623861 cites W2019071303 @default.
- W2953623861 cites W2040391753 @default.
- W2953623861 cites W2053559585 @default.
- W2953623861 cites W2053806803 @default.
- W2953623861 cites W2060079549 @default.
- W2953623861 cites W2063528788 @default.
- W2953623861 cites W2064049619 @default.
- W2953623861 cites W2072965584 @default.
- W2953623861 cites W2081227651 @default.
- W2953623861 cites W2083472277 @default.
- W2953623861 cites W2092907596 @default.
- W2953623861 cites W2097781495 @default.
- W2953623861 cites W2101020994 @default.
- W2953623861 cites W2112471413 @default.
- W2953623861 cites W2116045728 @default.
- W2953623861 cites W2118876291 @default.
- W2953623861 cites W2119852447 @default.
- W2953623861 cites W2126452437 @default.
- W2953623861 cites W2130845266 @default.
- W2953623861 cites W2137460740 @default.
- W2953623861 cites W2137959339 @default.
- W2953623861 cites W2146225278 @default.
- W2953623861 cites W2292328129 @default.
- W2953623861 cites W2300579058 @default.
- W2953623861 cites W2509676484 @default.
- W2953623861 cites W2519634482 @default.
- W2953623861 cites W2559773518 @default.
- W2953623861 cites W2596457116 @default.
- W2953623861 cites W2606003960 @default.
- W2953623861 cites W2611241853 @default.
- W2953623861 cites W2625655844 @default.
- W2953623861 cites W2741297834 @default.
- W2953623861 cites W2754128384 @default.
- W2953623861 cites W2791881027 @default.
- W2953623861 cites W2917267661 @default.
- W2953623861 cites W4255037836 @default.
- W2953623861 doi "https://doi.org/10.2147/clep.s201983" @default.
- W2953623861 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6607979" @default.
- W2953623861 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31388316" @default.
- W2953623861 hasPublicationYear "2019" @default.
- W2953623861 type Work @default.
- W2953623861 sameAs 2953623861 @default.
- W2953623861 citedByCount "13" @default.
- W2953623861 countsByYear W29536238612019 @default.
- W2953623861 countsByYear W29536238612020 @default.
- W2953623861 countsByYear W29536238612021 @default.
- W2953623861 countsByYear W29536238612022 @default.
- W2953623861 countsByYear W29536238612023 @default.
- W2953623861 crossrefType "journal-article" @default.
- W2953623861 hasAuthorship W2953623861A5018869790 @default.
- W2953623861 hasAuthorship W2953623861A5034203110 @default.
- W2953623861 hasAuthorship W2953623861A5040245841 @default.
- W2953623861 hasAuthorship W2953623861A5048126509 @default.
- W2953623861 hasAuthorship W2953623861A5062493290 @default.
- W2953623861 hasAuthorship W2953623861A5085651175 @default.
- W2953623861 hasBestOaLocation W29536238611 @default.
- W2953623861 hasConcept C126322002 @default.
- W2953623861 hasConcept C127413603 @default.
- W2953623861 hasConcept C134018914 @default.
- W2953623861 hasConcept C164705383 @default.
- W2953623861 hasConcept C167135981 @default.
- W2953623861 hasConcept C1862650 @default.
- W2953623861 hasConcept C201903717 @default.
- W2953623861 hasConcept C2776839432 @default.
- W2953623861 hasConcept C2777482532 @default.
- W2953623861 hasConcept C2780645631 @default.
- W2953623861 hasConcept C2908647359 @default.
- W2953623861 hasConcept C50382708 @default.
- W2953623861 hasConcept C555293320 @default.
- W2953623861 hasConcept C71924100 @default.
- W2953623861 hasConcept C72563966 @default.
- W2953623861 hasConcept C73269764 @default.
- W2953623861 hasConcept C78519656 @default.
- W2953623861 hasConcept C99454951 @default.
- W2953623861 hasConceptScore W2953623861C126322002 @default.
- W2953623861 hasConceptScore W2953623861C127413603 @default.
- W2953623861 hasConceptScore W2953623861C134018914 @default.
- W2953623861 hasConceptScore W2953623861C164705383 @default.
- W2953623861 hasConceptScore W2953623861C167135981 @default.
- W2953623861 hasConceptScore W2953623861C1862650 @default.
- W2953623861 hasConceptScore W2953623861C201903717 @default.